Are you concerned about sending your DNA sequences overseas? Novel Bio is a North American Organization with labs in US and Canada. With our highly efficient NBx platform, we can handle difficult constructs with ease and our white glove service further enhances the customer experience. If you are struggling with your plasmid supplier, reach out to us!
Novel Biotechnology Inc.’s Post
More Relevant Posts
-
Discover how TR-FRET Assay can simplify and accelerate your drug discovery! TR-FRET is a powerful technique commonly used to analyze the binding of two interacting molecules. With over 90 assay kits in the TR-FRET format, we may have perfect options for your research! #drugdiscovery #TRFRET #assaydevelopment https://hubs.ly/Q02mLGTC0
To view or add a comment, sign in
-
-
Don't miss it! Next week you can follow our SCREEN-seq webinar LIVE! In the webinar we explain what SCREEN-seq is and how it can accelerate drug discovery screening projects by adding high throughput bulk sequencing to your research. Register through the link in our post below!
Our SCREEN-Seq Webinar takes place 27th June! Oriol Battle, team lead R&D at SCD, will present how SCREEN-seq is used for high-throughput drug screens to speed up drug discovery by including transcriptomic information from cell lines or organoids . Register FOC using the link below: https://hubs.ly/Q02CcPhK0 #organoids #highthroughput #drugdiscovery #RNAsequencing
To view or add a comment, sign in
-
-
Unlocking the future of drug discovery! Harness the power of our in-house Cryo-EM at XralPi to revolutionize how you gather insights on target structures and facilitate drug discovery. Dive deeper into our capabilities by clicking the link below!
Structure determination is mission-critical for early drug discovery. XtalPi offers a robust suite of technologies to solve even the most complex protein structures. Watch our on-demand webinar now to learn how our CryoEM platform solved the structure of a GPCR-Fab complex, a PROTAC complex, and a target-molecule octamer. View now at https://hubs.li/Q02t8My00 #cryoEM #drugdiscovery #structuredetermination
To view or add a comment, sign in
-
-
Don't miss it! Next week you can follow our SCREEN-seq webinar LIVE! In the webinar we explain what SCREEN-seq is and how it can accelerate drug discovery screening projects by adding high throughput bulk sequencing to your research. Register through the link in our post below!
Our SCREEN-Seq Webinar takes place 27th June! Oriol Battle, team lead R&D at SCD, will present how SCREEN-seq is used for high-throughput drug screens to speed up drug discovery by including transcriptomic information from cell lines or organoids . Register FOC using the link below: https://hubs.ly/Q02CcPhK0 #organoids #highthroughput #drugdiscovery #RNAsequencing
To view or add a comment, sign in
-
-
Ever wished you had an unbiased whole transcriptome readout for a (drug) screen? Check out our recently launched service SCREEN-seq and register for our webinar to learn how SCREEN-seq can help you find more targets and understand MoA much faster!
Our SCREEN-Seq Webinar takes place 27th June! Oriol Battle, team lead R&D at SCD, will present how SCREEN-seq is used for high-throughput drug screens to speed up drug discovery by including transcriptomic information from cell lines or organoids . Register FOC using the link below: https://hubs.ly/Q02CcPhK0 #organoids #highthroughput #drugdiscovery #RNAsequencing
To view or add a comment, sign in
-
-
Maintaining consistency in molecular diagnostics is a huge challenge, especially with complex assembly processes and inconsistent materials. However, Porex's recent custom solution led to an impressive advancement in operational efficiency without compromising on quality or regulatory standards. Discover how we tackled this issue in our latest application case study! Dive in: https://bit.ly/4byGymZ #MolecularDiagnostics #AssayCartridge
Molecular Diagnostics Assay Cartridge Application Case Study
learn.porex.com
To view or add a comment, sign in
-
The technology at work in the ViennaLab RealFast™ Assays RealFast™ Assays contain hydrolysis probes, also commonly called TaqMan® probes. The sequence-specific oligonucleotide probes carry a fluorescent reporter dye at the 5´-end and a quencher dye at the 3´-end. While the probe is intact, the quencher is close enough to the reporter to suppress the fluorescent signal of the 5´-fluorophore. During the continuous annealing/extension phase of PCR, the probe is cleaved by the 5´ to 3´ exonuclease activity of Taq DNA polymerase, thereby spatially separating the fluorophore from the quencher dye. This process results in detectable fluorescence, which is proportional to the amount of accumulated PCR product. #Viennalab #HVDLIFESCIENCES #REALFASTASSAYS https://lnkd.in/dDug4DRR
Distribution
viennalab.com
To view or add a comment, sign in
-
Explore Logica's innovative risk-sharing model for small molecule drug discovery. Our success is tied to yours, accelerating your outcome and reducing your risk. Discover your optimal solution with our unique approach. https://okt.to/LxAZdF #smallmolecule #drugdiscovery #logica
To view or add a comment, sign in
-
Selecting the right bioanalytical testing platform for your small or large molecule is a foundational part of your #DrugDevelopment program. Here’s an overview of the top platforms used for small and large molecule bioanalysis. https://hubs.li/Q02gcdTT0
7 Most Common Bioanalytical Testing Platforms for Small and Large Molecule Bioanalysis
To view or add a comment, sign in
-
At WADC in London our team presented a poster showcasing our unique ThioBridge™ conjugation technology that's been proven to improve the stability, potency and efficacy of antibody-drug conjugates (#ADCs). ThioBridge™ addresses key challenges in ADC design and development by leveraging naturally occurring interchain disulfide bonds. This results in a more uniform drug-to-antibody ratio (DAR) profile, improved linker stability and precise site-specificity, ensuring no deconjugation or cross-conjugation issues. Biopharma developers: How might this technology impact your ADC pipeline? Let's discuss the potential for improved efficacy and safety profiles today! Access the poster here to learn more: https://lnkd.in/eU8p5ima
To view or add a comment, sign in
-